These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21225026)

  • 1. A report from the 13th International Conference on Alzheimer's Disease and Related Disorders (ICAD) (July 10-15, 2010-Honolulu, Hawaii, USA).
    Rabasseda X
    Drugs Today (Barc); 2010 Nov; 46(11):875-87. PubMed ID: 21225026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICAD 2010: Detection may hold the key to treatment. International Conference on Alzheimer Disease (ICAD) 2010 Honolulu, HI, USA, 10–15 July 2010.
    Sano M
    Expert Rev Neurother; 2010 Nov; 10(11):1659-61. PubMed ID: 20977323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia and Alzheimer's disease: clinical presentation, cognitive testing, pathology and response to 1-deprenyl therapy.
    Ruehl WW; Bruyette DS; DePaoli A; Cotman CW; Head E; Milgram NW; Cummings BJ
    Prog Brain Res; 1995; 106():217-25. PubMed ID: 8584657
    [No Abstract]   [Full Text] [Related]  

  • 4. Meeting report: the Fifth International Conference on Alzheimer's Disease and Related Disorders.
    Kalaria RN; Giacobini E
    Alzheimer Dis Assoc Disord; 1997 Jun; 11(2):113-9. PubMed ID: 9194959
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of vascular disease in dementia: what does industry want to know?
    Wren PB; Hill D; Lockhart A
    Clin Sci (Lond); 2017 May; 131(9):799-802. PubMed ID: 28424374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Vitamin D and cognition in older adults': updated international recommendations.
    Annweiler C; Dursun E; Féron F; Gezen-Ak D; Kalueff AV; Littlejohns T; Llewellyn DJ; Millet P; Scott T; Tucker KL; Yilmazer S; Beauchet O
    J Intern Med; 2015 Jan; 277(1):45-57. PubMed ID: 24995480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension, cognitive decline, and dementia: an epidemiological perspective.
    Tzourio C
    Dialogues Clin Neurosci; 2007; 9(1):61-70. PubMed ID: 17506226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's Association International Conference on Alzheimer's Disease 2015 (AAIC 2015) (July 18-23, 2015 - Washington, D.C., USA).
    Mason VL
    Drugs Today (Barc); 2015 Jul; 51(7):447-52. PubMed ID: 26261847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
    Gauthier S; Poirier J
    Alzheimers Dement; 2009 Mar; 5(2):147-8. PubMed ID: 19328447
    [No Abstract]   [Full Text] [Related]  

  • 10. A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders.
    Salmon E
    J Neural Transm (Vienna); 2007 Sep; 114(9):1179-85. PubMed ID: 17308980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Disease Drug Discovery--11th International Conference--Promising New Therapeutic Approaches. 27-28 September 2010, Jersey City, NJ, USA.
    Wolfe MS
    IDrugs; 2010 Dec; 13(12):825-7. PubMed ID: 21154134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 12th International Conference on Alzheimer's Disease (ICAD), Vienna, Austria.
    Strobel G
    J Alzheimers Dis; 2009; 18(4):973-90. PubMed ID: 20009238
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Subjective cognitive impairment as an antecedent of Alzheimer's dementia: policy import.
    Reisberg B; Shulman MB
    Alzheimers Dement; 2009 Mar; 5(2):154-6. PubMed ID: 19328449
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescribing drugs for Alzheimer's disease in primary care: managing cognitive symptoms.
    Drug Ther Bull; 2014 Jun; 52(6):69-72. PubMed ID: 24924683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Alzheimer's disease: how to estimate the impact of the pathology and the treatment?].
    Delrieu J; Vellas B
    Therapie; 2010; 65(5):423-8. PubMed ID: 21144477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease and mild cognitive impairment.
    Kelley BJ; Petersen RC
    Neurol Clin; 2007 Aug; 25(3):577-609, v. PubMed ID: 17659182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease.
    de Oliveira FF; Bertolucci PH; Chen ES; Smith Mde A
    J Neurol Sci; 2014 Jan; 336(1-2):103-8. PubMed ID: 24189208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease in the zebrafish: where can we take it?
    Caramillo EM; Echevarria DJ
    Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):179-186. PubMed ID: 28177980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.
    Hussain H
    Neurology; 2007 Jul; 69(4):409. PubMed ID: 17646640
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug development in dementia.
    Cunningham EL; Passmore AP
    Maturitas; 2013 Nov; 76(3):260-6. PubMed ID: 23707728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.